1-16 of 16
Adam Lamble
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Free
Alex Herrera, Michael Leblanc, Sharon Castellino, Hongli Li, Sarah Rutherford, Andrew Evens, Kelly Davison, Susan Parsons, Sairah Ahmed, Carla Casulo, Nancy Bartlett, Joseph Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Boyu Hu, Craig Moskowitz, Christopher Forlenza, Andrew Doan, Adam Lamble, David Hodgson, Anca Prica, Michael Knopp, Tricia Hernandez, Richard Little, Margaret Shipp, Michael Crump, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg
Journal: Blood
Blood (2025) 146 (Supplement 1): 151.
https://doi.org/10.1182/blood-2025-151
Published: 2025
Journal Articles

TP53 inactivation confers resistance to the menin inhibitor revumenib in Acute Myeloid Leukemia

Free
Jeevitha D'Souza, Camille Leung, Aishwarya Ballapuram, Abigail S. Lin, Alexa Rane Batingana, Adam Lamble, Rhonda Ries, Carolina Morales, Charisa Cottonham, Pranav Gona, Li Fan, Xiaotu Ma, Kevin Shannon, Soheil Meshinchi, Benjamin Braun, Benjamin Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3470.
https://doi.org/10.1182/blood-2025-3470
Published: 2025
Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Free
Lisa Giulino Roth, Mario Melgar Toledo, Frank G. Keller, Bradford Hoppe, Christopher J. Forlenza, Sharon M. Castellino, Maitane Andión Catalan, Julie Krystal, Adam Lamble, Flavio Luisi, Fabio Molina Morales, Aarati V. Rao, Stacy Cooper, Oscar Gonzalez Llano, Luis Juarez Villegas, Christine Mauz-Koerholz, Juan Shen, Pallavi Pillai, Rushdia Yusuf, Kara M. Kelly
Journal: Blood
Blood (2024) 144 (Supplement 1): 462.
https://doi.org/10.1182/blood-2024-199263
Published: 2024
Journal Articles

Contrasting Clinical Implications of NRAS Vs. KRAS Mutations in AML - Only KRAS Mutations Are Associated with Adverse Outcome

Free
John N Colgan, Jack H. Peplinski, Danielle C. Kirkey, Adam Lamble, Rhonda E. Ries, Soheil Meshinchi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1555.
https://doi.org/10.1182/blood-2024-202833
Published: 2024
Journal Articles

Comprehensive Characterization of Rare Recurrent Mutations in Pediatric AML

Free
Adam Lamble, Rhonda E. Ries, Jack H. Peplinski, Logan K. Wallace, Danielle C. Kirkey, Xiaotu Ma, Soheil Meshinchi
Journal: Blood
Blood (2024) 144 (Supplement 1): 849.
https://doi.org/10.1182/blood-2024-208864
Published: 2024
Journal Articles

Clinical Factors Associated with Prolonged Cytopenias after CD19 Chimeric Antigen Receptor T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Free
Regina M. Myers, Yimei Li, Adam Lamble, Emily M. Hsieh, Samuel John, Gregory Dolan, Hongyan Liu, Lee Chen, Jennifer Sheppard, Amanda M. DiNofia, Colleen Annesley, Stephan A. Grupp, Deepa Bhojwani, Rebecca A. Gardner, Lia Gore, Susan R Rheingold, Nirali N. Shah, Michael A. Pulsipher
Journal: Blood
Blood (2024) 144 (Supplement 1): 4827.
https://doi.org/10.1182/blood-2024-202027
Published: 2024
Journal Articles

Monocytic Differentiation in B-Lymphoblastic Leukemia with CRLF2 rearrangement at Diagnosis: Implications for Pathogenesis and Post-Therapeutic Lineage Switch

Free
Alexandra E. Kovach, Sara K. Silbert, Annie Luong, Gerald Lu, Michael Lu, Hao-Wei Wang, Karen M Chisholm, Andrew Doan, Deepa Bhojwani, Adam Lamble, Nirali N. Shah, Chintan Parekh, Gordana Raca, Brent L. Wood
Journal: Blood
Blood (2024) 144 (Supplement 1): 2799.
https://doi.org/10.1182/blood-2024-198961
Published: 2024
Journal Articles

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS

Free
Sara K. Silbert, Cynthia Harrison, D. Nathan Biery, Alexandra Semchenkova, Elena Zerkalenkova, Anna Alonso-Saladrigues, Kaylyn Utley, Ibrahim Aldoss, Liping Zhao, Sneha Fernandes, Jeremy D. Rubinstein, Naomi Torres Carapia, Bill H. Chang, Anant Vatsayan, Barbara De Moerloose, Holly L. Pacenta, Dennis John Kuo, Gabriele Escherich, Benjamin J. Lee, Michele S. Redell, Mandi R. Fitzjohn, Daniel P. Larson, Nicolas Duployez, Raymund S. Cuevo, Rui Rochelle He, David Dickens, Firas El Chaer, Kelly Reed, Matthias Wolfl, Sunil S. Raikar, Süreyya Savaşan, Latika Puri, Zhubin J. Gahvari, Aimee C. Talleur, Hisham Abdel-Azim, Aghiad Chamdin, Marlie R.M. Provost, Vanessa A. Fabrizio, Kerstin Mezger, Alexandra McLean Stevens, Emily M. Hsieh, Hao-Wei Wang, Constance M. Yuan, Ulrich A. Duffner, Jing Pan, Sara Ghorashian, Susana Rives, Chloe Hoang, Kara L. Davis, Elad Jacoby, Alexander Popov, Adam Lamble, Nirali N. Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4202.
https://doi.org/10.1182/blood-2023-182293
Published: 2023
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Free
Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Free
Lisa Giulino Roth, Frank Keller, Mario Melgar Toledo, Sharon M. Castellino, Christopher J. Forlenza, Maitane Andión Catalan, Julie Krystal, Adam Lamble, Aarati V. Rao, Fabio Molina Morales, Stacy Cooper, Flavio Luisi, Oscar Gonzalez Llano, Karla Alejandra Lopez, Christine Mauz-Koerholz, Bradford Hoppe, Juan Shen, Pallavi Pillai, Patricia Marinello, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 1700.
https://doi.org/10.1182/blood-2023-186719
Published: 2023
Journal Articles

Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Free
Benjamin J Huang, Lauren K. Meyer, Adam Lamble, Jim Wang, Rhonda E Ries, Alan S Gamis, Richard Aplenc, Katherine Tarlock, Todd Cooper, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Joseph Chewning, William G. Woods, John T. Horan
Journal: Blood
Blood (2023) 142 (Supplement 1): 655.
https://doi.org/10.1182/blood-2023-186955
Published: 2023
Journal Articles

Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph + ALL

Free
Brief Report
Jessica T. Leonard, Yoko Kosaka, Pavani Malla, Dorian LaTocha, Adam Lamble, Brandon Hayes-Lattin, Kaelan Byrd, Brian J. Druker, Jeffrey W. Tyner, Bill H. Chang, Evan Lind
Journal: Blood
Blood (2021) 137 (7): 939–944.
https://doi.org/10.1182/blood.2020005655
Published: 2021
Journal Articles

CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

Free
David K. Edwards, V, Kevin Watanabe-Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam Lamble, Evan F. Lind, Andy Kaempf, Motomi Mori, Mara Rosenberg, Amanda d’Almeida, Nicola Long, Anupriya Agarwal, David Tyler Sweeney, Marc Loriaux, Shannon K. McWeeney, Jeffrey W. Tyner
Journal: Blood
Blood (2019) 133 (6): 588–599.
https://doi.org/10.1182/blood-2018-03-838946
Published: 2019
Includes: Supplemental data
Journal Articles

Mass Cytometry As a Modality to Identify Candidates for Immune Checkpoint Inhibitor Therapy within Acute Myeloid Leukemia

Free
Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 2829.
https://doi.org/10.1182/blood.V128.22.2829.2829
Published: 2016
Journal Articles

Enhanced VISTA Expression in a Subset of Patients with Acute Myeloid Leukemia

Free
Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 4056.
https://doi.org/10.1182/blood.V128.22.4056.4056
Published: 2016
Journal Articles

Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia

Free
Adam Lamble, MD, Yoko Kosaka, PhD, Pierrette Lo, MS, Fei Huang, PhD, Kate Sasser, PhD, Cristina E. Tognon, PhD, Marc Loriaux, MD PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2015) 126 (23): 1374.
https://doi.org/10.1182/blood.V126.23.1374.1374
Published: 2015